SIGGF (Sigma Healthcare) Research & Development: $0 Mil (TTM As of Dec. 2025)


SIGGF Sigma Healthcare Ltd SIGGF
59 GF Score
Price $2.35
GF Value $0.31
! 8 Warning Signs
View Full Analysis

What is Sigma Healthcare Research & Development?

Sigma Healthcare SIGGF 59 Research & Development is $0 Mil as of Dec. 2025. GuruFocus rates SIGGF with a GF Score™ of 59/100 and a GF Value™ of $0.31. The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Sigma Healthcare's Research & Development for the six months ended in Dec. 2025 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0 Mil.

Sigma Healthcare  (OTCPK:SIGGF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sigma Healthcare Research & Development Related Terms

Sigma Healthcare Research & Development Historical Data

* Premium members only.

The historical data trend for Sigma Healthcare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sigma Healthcare Research & Development Chart

Sigma Healthcare Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sigma Healthcare Semi-Annual Data
Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SIGGF
59GF Score
Sigma Healthcare Ltd SIGGF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sigma Healthcare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Sigma Healthcare (SIGGF) has a Research & Development of $0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Sigma Healthcare and its competitors.
Is Sigma Healthcare's Research & Development too high?
Sigma Healthcare's current Research & Development is $0 Mil. Overall, Sigma Healthcare has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's Research & Development compare to MCK and COR?
Sigma Healthcare's Research & Development of $0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Distribution company?
A good Research & Development depends on the Medical Distribution industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Sigma Healthcare and its competitors. Sigma Healthcare's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Sigma Healthcare (SIGGF) has a current Research & Development of $0 Mil. The stock's GF Value™ is $0.31, compared to a current price of $2.35 — trading 657.4% above its estimated fair value. The current Research & Development is $0 Mil. Sigma Healthcare's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Sigma Healthcare (SIGGF), the current Research & Development is $0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sigma Healthcare (SIGGF) Overvalued in 2026?

Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued. The current stock price of $2.35 is trading 657.4% above its estimated GF Value™ of $0.31.

Key valuation signals for SIGGF:

  • Research & Development: $0 Mil
  • GF Value™: $0.31 vs. price of $2.35 (657.4% above fair value)
  • GF Score™: 59/100 with 8 warning signs

No single metric tells the full story. See the SIGGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sigma Healthcare Business Description

Other Exchanges SIG:Australia
Address 6 Albert Street, Preston, VIC, AUS, 3072
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
59GF Score

Get the complete analysis for SIGGF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.35
Price
$0.31
GF Value